SCHEMBL18112641

SCHEMBL18112641

CC(=O)CCCCn1c(=O)c2c(nc(C#CC(C)(C)O)n2C)n(C)c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 4/20 0.53
TNF P01375 4/20 0.53
ADORA2B P29275 4/20 0.53
LMNA P02545 3/20 0.53
PDE4B Q07343 3/20 0.53
PDE4C Q08493 3/20 0.53
PDE4D Q08499 3/20 0.53
CYP1A2 P05177 2/20 0.53
NFKB1 P19838 2/20 0.53
ACHE P22303 2/20 0.53
PMP22 Q01453 2/20 0.53
RXFP1 Q9HBX9 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
USP2 O75604 1/20 0.53
TSHR P16473 1/20 0.53
ESR1 P03372 1/20 0.49
MAPT P10636 1/20 0.49
BLM P54132 1/20 0.49
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18112645 0.79 LMNA (0.49) PDE4ATNFADORA2BLMNAPDE4B
SCHEMBL18112640 0.79 LMNA (0.48) PDE4ATNFADORA2BLMNAPDE4B
SCHEMBL18112909 0.79 LMNA (0.48) PDE4ATNFADORA2BLMNAPDE4B
SCHEMBL18112647 0.78 KMT2A (0.45) ADORA2BRXFP1MAPTMAPK1ADORA2A
SCHEMBL18112643 0.78 LMNA (0.47) PDE4ATNFADORA2BLMNAPDE4B
SCHEMBL8060268 0.78 TNF (0.63) PDE4ATNFADORA2BLMNAPDE4B
SCHEMBL18119890 0.77 TNF (0.67) PDE4ATNFADORA2BLMNAPDE4B
SCHEMBL18112646 0.76 TNF (0.46) PDE4ATNFADORA2BLMNAPDE4B
SCHEMBL19556694 0.76 PDE4A (0.58) PDE4ATNFADORA2BLMNAPDE4B
SCHEMBL18120220 0.75 LMNA (0.45) PDE4ATNFADORA2BLMNAPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016159746-A1 NOVEL ETHYNYLXANTHINES, THEIR PREPARATION AND USE AS INHIBITORS OF MATRIX METALLOPROTEINASES AND ANGIOGENESIS LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2016-10-06 WO claimed
WO-2016159745-A1 ETHYNYLXANTHINES, PREPARATION AND USE FOR CANCER TREATMENT LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2016-10-06 WO claimed
WO-2016159746-A1 NOVEL ETHYNYLXANTHINES, THEIR PREPARATION AND USE AS INHIBITORS OF MATRIX METALLOPROTEINASES AND ANGIOGENESIS LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2016-10-06 WO disclosed
WO-2016159747-A1 ETHYNYLXANTHINES, PREPARATION AND USE AS CALCIUM ION CHANNEL MODULATORS LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2016-10-06 WO disclosed
WO-2016159746-A1 NOVEL ETHYNYLXANTHINES, THEIR PREPARATION AND USE AS INHIBITORS OF MATRIX METALLOPROTEINASES AND ANGIOGENESIS LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2016-10-06 WO disclosed
WO-2016159745-A1 ETHYNYLXANTHINES, PREPARATION AND USE FOR CANCER TREATMENT LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2016-10-06 WO disclosed
WO-2016159745-A1 ETHYNYLXANTHINES, PREPARATION AND USE FOR CANCER TREATMENT LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) 2016-10-06 WO disclosed